Our present study demonstrated that CDKN2A expression was positively correlated with the infiltration levels of CD4+ T cells, macrophages, and cancer-associated fibroblasts, suggesting its apparent potential role in promoting tumor progression through remodeling the immune microenvironment. The gene discussed is CD4; the disease is cancer.